The DASH diet and insulin sensitivity.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 3767170)

Published in Curr Hypertens Rep on February 01, 2011

Authors

Alan L Hinderliter1, Michael A Babyak, Andrew Sherwood, James A Blumenthal

Author Affiliations

1: Department of Medicine, Division of Cardiology, University of North Carolina, Chapel Hill, NC 27599-7075, USA. hinderli@med.unc.edu

Articles cited by this

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66

Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA (2003) 13.82

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab (2000) 11.97

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet (2000) 9.78

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ (2003) 8.55

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab (2007) 6.91

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet (2007) 6.80

Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med (2008) 4.03

Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care (1998) 3.30

Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract (2000) 3.13

Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev (2008) 3.11

Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med (2010) 2.58

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J (1986) 2.55

Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med (1999) 2.51

Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes (1999) 2.48

Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care (1995) 2.33

Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg (2008) 2.19

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens (1993) 2.01

Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. J Hypertens (2007) 1.96

Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Arch Intern Med (2008) 1.89

Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care (2003) 1.87

Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care (2009) 1.78

Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. Arch Intern Med (2000) 1.69

Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care (1999) 1.45

Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes (1987) 1.40

The epidemiology of impaired glucose tolerance and hypertension. Am Heart J (1991) 1.38

Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol (1985) (1996) 1.37

The effect of the PREMIER interventions on insulin sensitivity. Diabetes Care (2004) 1.36

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care (1997) 1.27

Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention. Diabetologia (1992) 1.16

Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension (2007) 1.09

Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ (2003) 1.07

The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study. JAMA (1990) 1.03

Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension (2010) 0.98

Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Diabetes Care (1992) 0.96

Acute reversal of the enhanced insulin action in trained athletes. Association with insulin receptor changes. Diabetes (1985) 0.94

Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care (1984) 0.92

Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia. Diabetes (1998) 0.91

Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in nonobese subjects? Med Sci Monit (2002) 0.87

Effects of training and detraining on dose-response relationship between glucose and insulin secretion. Am J Physiol (1989) 0.86

Are you what you eat, or how much you eat? The case of type 2 diabetes mellitus. Arch Intern Med (2008) 0.81

Articles by these authors

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36

The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol (2005) 5.33

Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation (2008) 5.15

Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med (2007) 4.49

Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet (2003) 4.21

Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med (2004) 3.94

Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med (2010) 3.57

Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA (2012) 3.46

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41

Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34

Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol (2012) 3.19

Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83

Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study. Arch Pediatr Adolesc Med (2012) 2.70

Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med (2010) 2.58

Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol (2007) 2.57

Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50

Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med (2009) 2.34

Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med (2007) 2.33

Central nervous system injury associated with cardiac surgery. Lancet (2006) 2.27

Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA (2005) 2.18

Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol (2007) 2.08

Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension (2010) 2.07

Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke (2013) 2.05

Exercise and the treatment of clinical depression in adults: recent findings and future directions. Sports Med (2002) 2.02

Nighttime blood pressure dipping in postmenopausal women with coronary heart disease. Am J Hypertens (2012) 2.02

Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men. Am J Cardiol (2002) 1.92

Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med (2005) 1.88

Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med (2006) 1.87

Systolic blood pressure, socioeconomic status, and biobehavioral risk factors in a nationally representative US young adult sample. Hypertension (2011) 1.80

Emotional antecedents of hot flashes during daily life. Psychosom Med (2005) 1.77

Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. Psychosom Med (2003) 1.72

Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol (2011) 1.71

Ethnic differences in the treatment of depression in patients with ischemic heart disease. Am Heart J (2008) 1.70

Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med (2005) 1.70

Effects of a telephone-based psychosocial intervention for patients awaiting lung transplantation. Chest (2002) 1.66

History of depression and survival after acute myocardial infarction. Psychosom Med (2009) 1.65

Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64

Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens (2002) 1.56

Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction. Psychosom Med (2007) 1.56

Associations among perceptions of social support, negative affect, and quality of sleep in caregivers and noncaregivers. Health Psychol (2006) 1.56

Hostility, social support, and adrenergic receptor responsiveness among African-American and white men and women. Psychosom Med (2003) 1.55

Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized controlled study. Pain (2011) 1.55

Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med (2006) 1.51

Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol (2005) 1.47

Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction. Anesth Analg (2002) 1.41

Sex differences in the endothelial function of untreated hypertension. J Clin Hypertens (Greenwich) (2012) 1.39

Pain catastrophizing and pain-related fear in osteoarthritis patients: relationships to pain and disability. J Pain Symptom Manage (2008) 1.39

Telephone-based coping skills training for patients awaiting lung transplantation. J Consult Clin Psychol (2006) 1.33

Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J Am Heart Assoc (2013) 1.32

Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence. Ann Behav Med (2010) 1.32

Association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women. Int J Behav Med (2006) 1.31

Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J Psychosom Res (2004) 1.30

Exercise training and depression in older adults. Neurobiol Aging (2005) 1.28

Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. J Am Coll Cardiol (2007) 1.27

The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg (2002) 1.24

Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. Psychosom Med (2007) 1.22

Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. Arch Intern Med (2003) 1.21

Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). Am J Cardiol (2009) 1.21

The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study. Psychosom Med (2014) 1.20

Relation between volume of exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol (2012) 1.20

Perceived social support as a predictor of mortality in coronary patients: effects of smoking, sedentary behavior, and depressive symptoms. Psychosom Med (2005) 1.18

Determinants and consequences of adherence to the dietary approaches to stop hypertension diet in African-American and white adults with high blood pressure: results from the ENCORE trial. J Acad Nutr Diet (2012) 1.17

Pain coping skills training and lifestyle behavioral weight management in patients with knee osteoarthritis: a randomized controlled study. Pain (2012) 1.13

Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Am Heart J (2006) 1.11

Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc (2004) 1.10

Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. Psychosom Med (2010) 1.09

Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. Am Heart J (2003) 1.09